Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Pharmacodynamics
- 16 Sep 2019 Status changed from recruiting to completed.
- 04 Jul 2019 Results assessing if urine could provide a biomarker of adherence for currently approved PrEP and HIV treatment regimens published in the JAIDS
- 07 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.